LivaNova · 1 month ago
Operating Room Support Specialist, VNS - Part Time (San Antonio,TX)
LivaNova is a global medtech company focused on changing lives through innovative healthcare solutions. They are looking for an Operating Room Support Specialist to assist in the surgical implantation of the Vagus Nerve Stimulator, collaborating with medical professionals to support patients with epilepsy.
Health CareMedical DeviceNeuroscience
Responsibilities
Understand the implantation, operating room, and credentialing process
Gain or know the local hospitals
Be available to work with short notice 1-2 days, no more than 29 hours a week
Become a highly trained, subject matter expert responsible for surgical case coverage in the OR during implantation of the Vagus Nerve Stimulator (VNS) Therapy System
Support Operating Room staff in product-related matters intraoperative, including VNS diagnostics, troubleshooting, and programming assistance
Comply with hospital credentialing and access requirements (including any necessary immunizations as are required for healthcare employment)
Qualification
Required
BS/BA degree or clinical technical/operating room environment experience
Ability to project a positive image
Must be computer literate with proficiency in MS Office software
Exceptional written and verbal communication skills and nonverbal skills to communicate in the OR
Maintain all required necessary immunizations for healthcare employment as described above
Company
LivaNova
LivaNova is a medical technology company that specializes in advanced cardiac surgery, neuromodulation, and circulatory support solutions.
H1B Sponsorship
LivaNova has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (15)
2024 (7)
2023 (6)
2022 (7)
2021 (9)
2020 (7)
Funding
Current Stage
Public CompanyTotal Funding
$300M2024-03-05Post Ipo Debt· $300M
2015-10-19IPO
Recent News
2025-12-24
MarketScreener
2025-12-02
Company data provided by crunchbase